Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-028245

Esperion Therapeutics, Inc. · ESPR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Joseph Lewis
10% Owner
Period of report
Nov 2, 2018
Accepted (ET)
Nov 5, 2018 · 7:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF3,F1,F2Nov 2, 2018S2,500$54.65D1,198,750D
Common StockF4,F1,F2Nov 2, 2018S37,500$55.25D1,161,250D
Common StockF5,F1,F2Nov 5, 2018S26,500$55.21D1,134,750D
Common StockF6,F1,F2Nov 5, 2018S6,500$56.19D1,128,250D
Common StockF7,F1,F2Nov 5, 2018S2,000$57.38D1,126,250D
Common StockF1,F2Nov 5, 2018S6,390$58.82D1,119,860D
Common StockF8,F1,F2Nov 5, 2018S13,610$59.48D1,106,250D
Common StockF1,F2Nov 5, 2018S5,000$60.28D1,101,250D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses